FDA Grants Accelerated Approval to Iberdomide Combination for Multiple Myeloma Based on MRD-Negative CR
Aug 14, 2026
View online
FDA Grants Accelerated Approval to Iberdomide Combination for Multiple Myeloma Based on MRD-Negative CR
Oral SERDs in Breast Cancer: Powerful Shift From Rescue to Platform Therapy
Andrea Necchi: Another Option for 2L Therapy of Advanced Clear Cell RCC?
Richard Sullivan: China’s Pharmaceutical Rise Signals a New Global Power Shift
UICC Invests €1.49 Million in Three International Cancer Research Projects
The 7th Emirates Oncology Society Annual Conference 2026
Spider-Man: Brand New Day’s Gene-Silencing Technology: Could It Fight Cancer?
Immunõ 2026: Global Virtual Congress on Immuno Oncology
The Clinical Research Mentorship Program – CRMP 2026
Cancer Research Horizons Childhood Cancer Therapeutic Catalyst 2026
7th Global Cancer Summit (GCS 2026)
IOS 2026 Best of ASCO
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
